Citigroup’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-47,005
Closed -$1.11M 5971
2023
Q4
$1.11M Buy
47,005
+28,591
+155% +$509K ﹤0.01% 2740
2023
Q3
$275K Sell
18,414
-30,183
-62% -$400K ﹤0.01% 3468
2023
Q2
$532K Sell
48,597
-185,699
-79% -$1.73M ﹤0.01% 3329
2023
Q1
$2.04M Buy
234,296
+4,709
+2% +$37.7K ﹤0.01% 2008
2022
Q4
$1.44M Buy
229,587
+118,504
+107% +$450K ﹤0.01% 2295
2022
Q3
$389K Sell
111,083
-151,321
-58% -$544K ﹤0.01% 3418
2022
Q2
$774K Buy
262,404
+256,894
+4,662% +$614K ﹤0.01% 2880
2022
Q1
$17K Sell
5,510
-15,220
-73% -$47.9K ﹤0.01% 5260
2021
Q4
$70K Buy
20,730
+8,706
+72% +$33.1K ﹤0.01% 4921
2021
Q3
$44K Buy
12,024
+4,225
+54% +$16.6K ﹤0.01% 4808
2021
Q2
$34K Buy
7,799
+234
+3% +$1.04K ﹤0.01% 5014
2021
Q1
$34K Sell
7,565
-42,983
-85% -$231K ﹤0.01% 4936
2020
Q4
$291K Buy
50,548
+34,224
+210% +$259K ﹤0.01% 4694
2020
Q3
$119K Sell
16,324
-876,140
-98% -$4.68M ﹤0.01% 4981
2020
Q2
$3.12M Sell
892,464
-10,891
-1% -$31.4K ﹤0.01% 2319
2020
Q1
$1.34M Sell
903,355
-443,935
-33% -$745K ﹤0.01% 2878
2019
Q4
$2.64M Buy
1,347,290
+355,463
+36% +$1.34M ﹤0.01% 2696
2019
Q3
$5.08M Buy
991,827
+409,692
+70% +$2.48M 0.01% 1926
2019
Q2
$4.17M Buy
582,135
+562,167
+2,815% +$6.37M 0.01% 2123
2019
Q1
$265K Buy
19,968
+2
+0% +$21 ﹤0.01% 4828
2018
Q4
$157K Buy
19,966
+3,000
+18% +$28.6K ﹤0.01% 5256
2018
Q3
$188K Buy
16,966
+6,751
+66% +$83.9K ﹤0.01% 5323
2018
Q2
$137K Buy
10,215
+9,297
+1,013% +$116K ﹤0.01% 5424
2018
Q1
$12K Buy
+918
New +$11.4K ﹤0.01% 6988
2016
Q2
Sell
-324
Closed 7526
2016
Q1
$0 Buy
+324
New +$401 ﹤0.01% 7847
2015
Q1
Sell
-482
Closed -$5K 7496
2014
Q4
$5K Buy
482
+439
+1,021% +$3.53K ﹤0.01% 6685
2014
Q3
$0 Buy
+43
New +$264 ﹤0.01% 7359

Other funds holding CBAY